Related Experiment Video
Updated: May 23, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Clinical and genetic determinants of torsade de pointes risk
Andrew J Sauer1, Christopher Newton-Cheh
1Center for Human Genetic Research, Cardiovascular Research Center, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA.
No abstract available in PubMed .
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Mechanism of Cardiac Arrhythmias
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Dysrhythmias II: Classification of Tachyarrhythmias

